Inhibition of EDHF by two new combinations of K +-channel inhibitors in rat isolated mesenteric arteries

British Journal of Pharmacology

Volumn 138, Issue 6, 2003, Pages 1031-1035

  Hinton, Jane M ^a   Langton, Philip D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Apamin; Ca 2+ activated K + channels; Charybdotoxin; EDHF; Endothelium; Maurotoxin; TRAM 39

Indexed keywords

1 ETHYL 2 BENZIMIDAZOLINONE; 2 (2 CHLOROPHENYL) 2,2 DIPHENYLACETONITRILE; 4 AMINOPYRIDINE; ACETONITRILE DERIVATIVE; ACETYLCHOLINE; APAMIN; CALCIUM ION; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; IMIDAZOLINE DERIVATIVE; MAUROTOXIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; TOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CALCIUM CONDUCTANCE; CELL POLARITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; ENDOTHELIUM CELL; EVOKED RESPONSE; HYPERPOLARIZATION; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ACETONITRILES; ANIMALS; APAMIN; BENZIMIDAZOLES; BIOLOGICAL FACTORS; CHARYBDOTOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENTERIC ARTERIES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, WISTAR; SCORPION VENOMS; SCORPIONS; TRITYL COMPOUNDS;

EID: 0037363729     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705171     Document Type: Article

References (16)

1. 2+-activated potassium channels. Mol. Pharmacol., 63, 409-418.
2. DOUGHTY, J.M., PLANE, F. & LANGTON, P.D. (1999). Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am. J. Physiol., 276, H1107-H1112.
3. ECKMAN, D.M., HOPKINS, N., MCBRIDE, C. & KEEF, K.D. (1998). Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid. Br. J. Pharmacol., 124, 181-189.
4. EDWARDS, G., GARDENER, M.J., FELETOU, M., BRADY, G., VANHOUTTE, P.M. & WESTON, A.H. (1999). Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br. J. Pharmacol., 128, 1064-1070.
5. FISSLTHALER, B., POPP, R., KISS, L., POTENLE, M., HARDER, D.R., FLEMMING, I. & BUSSE, R. (1999). Cytochrome P4502C is an EDHF synthase in coronary arteries. Nature, 401, 493-7.
6. GARCIA, M.L., KNAUS, H.-G., MUNUJOS, P., SLAUGHTER, R.S. & KACZOROWSKI, G.J. (1995). Charybdotoxin and its effects on potassium channels. Am. J. Physiol., 269, C1-C10.
7. + channel blockers involved in EDHF-mediated responses in rat superior mesenteric artery. Br. J. Pharmacol., 134, 1021-1028.
8. GRUNNET, M., JESPERSEN, T., ANGELO, K., FROKJAER-JENSEN, C., KLAERKE, D.A., OLESEN, S.P. & JENSEN, B.S. (2001). Pharmacological modulation of SK3 channels. Neuropharmacol., 40, 879-887.
9. HINTON, J.M. & LANGTON, P.D. (2001). Possible involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat mesenteric artery. J. Physiol., 536P.
10. HINTON, J.M., SABATIER, J.-M. & LANGTON, P.D. (2002). Maurotoxin and apamin in combination abolish EDHF-mediated relaxation of the rat mesenteric artery. Biophys. J., 82, 2740.
11. KHARRAT, R., MANSUELLE, P., SAMPIERI, F., CREST, M., OUGHIDENI, R., VANRIETSCHOTEN, J., MARTINEAUCLAIRE, M.F., ROCHAT, H. & ELAYEB, M. (1997). Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels. FEBS Lett., 406, 284-290.
12. NILIUS, B. & DROOGMANS, G. (2001). Ion channels and their functional role in vascular endothelium. Phys. Rev., 81, 1416-1459.
13. WALDRON, G.J. & GARLAND, C.J. (1994). Effect of potassium channel blockers on L-NAME insensitive relaxations in rat small mesenteric artery. Can. J. Physiol. Pharmacol., 72, 115.
14. Ca with 1-ethyl-2-benzimidazolinone evokes smooth muscle hyperpolarization in rat isolated mesenteric artery. Br. J. Pharmacol., 134, 1548-1554.
15. WICKENDEN, A.D., STOCKER, J., SILVIA, C.P. & WAGONER, P.K. (2000). 1-EBIO activates human small conductance calcium-activated potassium channels. Biophys. J., 78, 1231.
16. Ca1: a potential immunosuppressant. Proc. Natl. Acad. Sci. U.S.A. 97, 8151-8156.